EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dynamic extracellular vestibule of human SERT: Unveiling druggable potential with high-affinity allosteric inhibitors

Kristine Salomon iD, Ara M Abramyan iD, Per Plenge, Lingle Wang, Christoffer Bundgaard iD, Benny Bang-Andersen iD, Claus J Loland iD, Lei Shi iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2304089120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Kristine Salomon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Membrane Protein Dynamics, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copen…. Hauptthemen laut MEDLINE: Citalopram, Serotonin Plasma Membrane Transport Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, HHS | NIH | National Institute on Drug Abuse, Independent Research Fund Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The serotonin transporter (SERT) tightly regulates synaptic serotonin levels and has been the primary target of antidepressants. Binding of inhibitors to the allosteric site of human SERT (hSERT) impedes the dissociation of antidepressants bound at the central site and may enhance the efficacy of such antidepressants to potentially reduce their dosage and side effects. Here, we report the identification of a series of high-affinity allosteric inhibitors of hSERT in a unique scaffold, with the lead compound, Lu AF88273 (3-(1-(2-(1 H -indol-3-yl)ethyl)piperidin-4-yl)-6-chloro-1 H -indole), having 2.1 nM allosteric potency in inhibiting imipramine dissociation. In addition, we find that Lu AF88273 also inhibits serotonin transport in a noncompetitive manner. The binding pose of Lu AF88273 in the allosteric site of hSERT is determined with extensive molecular dynamics simulations and rigorous absolute binding free energy perturbation (FEP) calculations, which show that a part of the compound occupies a dynamically formed small cavity. The predicted binding location and pose are validated by site-directed mutagenesis and can explain much of the structure–activity relationship of these inhibitors using the relative binding FEP calculations. Together, our findings provide a promising lead compound and the structural basis for the development of allosteric drugs targeting hSERT. Further, they demonstrate that the divergent allosteric sites of neurotransmitter transporters can be selectively targeted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CitalopramSerotonin Plasma Membrane Transport ProteinsHumansAntidepressive AgentsSelective Serotonin Reuptake InhibitorsSerotonin

Stichwörter der Autor:innen

allosteric binding siteallosteric modulatorfree energy perturbationmolecular dynamicsserotonin transporter

Substanzen

Antidepressive AgentsCitalopramSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, human

Autor:innen und Institutionen

  • Laboratory for Membrane Protein Dynamics, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark.
  • Computational Chemistry and Molecular Biophysics Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, NIH, Baltimore, MD 21224.
  • Schrödinger, Inc., San Diego, CA 92121.
  • Schrödinger, Inc., New York, NY 10036.
  • Medicinal Chemistry and Translational DMPK, H. Lundbeck A/S, DK-2500 Copenhagen-Valby, Denmark.

ORCID-Profile: Kristine Salomon, Ara M Abramyan, Christoffer Bundgaard, Benny Bang-Andersen, Claus J Loland, Lei Shi

Förderung

  • Intramural NIH HHS
  • HHS | NIH | National Institute on Drug Abuse
  • Independent Research Fund Denmark
  • Lundbeck Foundation
  • Novo Nordisk Fonden
  • Carlsbergfondet

Zitieren

APA

Salomon, K., Abramyan, A. M., Plenge, P., Wang, L., Bundgaard, C., Bang-Andersen, B., Loland, C. J., & Shi, L. (2023). Dynamic extracellular vestibule of human SERT: Unveiling druggable potential with high-affinity allosteric inhibitors. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2304089120

Vancouver

Salomon K, Abramyan AM, Plenge P, Wang L, Bundgaard C, Bang-Andersen B, et al. Dynamic extracellular vestibule of human SERT: Unveiling druggable potential with high-affinity allosteric inhibitors. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2304089120

BibTeX
@article{Salomon2023,
  author = {Salomon, Kristine and Abramyan, Ara M and Plenge, Per and Wang, Lingle and Bundgaard, Christoffer and Bang-Andersen, Benny and Loland, Claus J and Shi, Lei},
  title = {Dynamic extracellular vestibule of human SERT: Unveiling druggable potential with high-affinity allosteric inhibitors},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2304089120}
}
Kostenlos starten →